Chloroquine as Antiviral Treatment in Coronavirus Infection 2020
Status:
Completed
Trial end date:
2020-12-17
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate whether the therapy with chloroquine phosphate (CQ, in
combination with telemedical approach) in addition to standard care is effective and safe in
reducing composite endpoint of COVID-19-related hospitalization or all cause death, in
ambulatory patients with SARS-SoV-2 infection at particular risk of serious complications due
to advanced age and/or comorbid conditions (in comparison with subjects not treated with CQ
but receiving standard care and supervised telemedically).